Mechanism of nitrogen metabolism-related parameters and enzyme activities in the pathophysiology of autism

BackgroundThere is evidence that impaired metabolism play an important role in the etiology of many neuropsychiatric disorders. Although this has not been investigated to date, several recent studies proposed that nitrogen metabolism-related parameters may have a pathophysiological role in autism.MethodsThe study enrolled 20 Saudi boys with autism aged 4 to 12 years and 20 healthy controls matched for age and gender. Levels of creatine, urea, ammonia, gamma-aminobutyric acid (GABA), glutamate:glutamine (Glu:Gln) ratio, and enzymatic activities of glutamate dehydrogenase, 5'-nucleotidase, and adenosine deaminase (ADA) were determined in plasma samples from both groups.ResultsWe found a significant elevation of creatine, 5'-nucleotidase, GABA, and glutamic acid and a significant decrease in the enzymatic activity of ADA and glutamine level in patients with autism compared with healthy controls. The most significant variation between the two groups was found in the Glu:Gln ratio.ConclusionA raised Glu:Gln ratio together with positive correlations in creatine, GABA, and 5'-nucleotidase levels could contribute to the pathophysiology of autism, and might be useful diagnostic markers. The mechanism through which these parameters might be related to autism is discussed in detail.

[1]  B. Goldin,et al.  L-Glutamate Dehydrogenases* , 1971 .

[2]  U. Schlattner,et al.  Functions and effects of creatine in the central nervous system , 2008, Brain Research Bulletin.

[3]  H. Faras,et al.  Autism spectrum disorders , 2010, Annals of Saudi medicine.

[4]  O. Erel,et al.  Adenosine deaminase and guanosine deaminase activities in sera of patients with viral hepatitis. , 1999, Memorias do Instituto Oswaldo Cruz.

[5]  P. Molinoff,et al.  Basic Neurochemistry: Molecular, Cellular and Medical Aspects , 1989 .

[6]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[7]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .

[8]  P. Couvreur,et al.  II. Glutamine and glutamate. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  P. L. Ipata,et al.  Metabolic regulation of ATP breakdown and of adenosine production in rat brain extracts. , 2004, The international journal of biochemistry & cell biology.

[10]  P. Smits,et al.  In vivo evidence against a role for adenosine in the exercise pressor reflex in humans. , 2005, Journal of applied physiology.

[11]  A. Bertrand,et al.  A one-step determination of serum 5'-nucleotidase using a centrifugal analyzer. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[12]  O. Boulat,et al.  Ammonia toxicity to the brain and creatine. , 2004, Molecular genetics and metabolism.

[13]  M. Tosetti,et al.  Creatine depletion in a new case with AGAT deficiency: clinical and genetic study in a large pedigree. , 2002, Molecular genetics and metabolism.

[14]  Samantha A. Stewart.  The effects of benzodiazepines on cognition. , 2005, The Journal of clinical psychiatry.

[15]  Graeme Milligan,et al.  Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers , 2006, The Journal of Neuroscience.

[16]  M. Ostrowska,et al.  Adenosine ecto-deaminase (ecto-ADA) from porcine cerebral cortex synaptic membrane , 2007, Brain Research.

[17]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[18]  A. Marowsky,et al.  Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme , 2006, Neuroscience.

[19]  P. Hof,et al.  Autism: neuropathology, alterations of the GABAergic system, and animal models. , 2005, International review of neurobiology.

[20]  Detlev Boison,et al.  Adenosine as a neuromodulator in neurological diseases. , 2008, Current opinion in pharmacology.

[21]  David G. Amaral,et al.  The promise and the pitfalls of autism research: An introductory note for new autism researchers , 2011, Brain Research.

[22]  Michael A Kayser.  Inherited metabolic diseases in neurodevelopmental and neurobehavioral disorders. , 2008, Seminars in pediatric neurology.

[23]  J. Hutton,et al.  Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease. , 1978, The Journal of clinical investigation.

[24]  J. Seegmiller,et al.  An enzymatic determination of ammonia in biological fluids. , 1965, The Journal of laboratory and clinical medicine.

[25]  A. El-Ansary,et al.  Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. , 2009, Clinical biochemistry.

[26]  P. Couvreur,et al.  I. Arginine : Free amino acids in human health and pathologies. Part 1 , 2002 .

[27]  A. El-Ansary,et al.  Metabolic biomarkers related to energy metabolism in Saudi autistic children. , 2009, Clinical biochemistry.

[28]  G. Stiles,et al.  Adenosine receptor subtypes: characterization and therapeutic regulation. , 1995, Annual review of pharmacology and toxicology.

[29]  T. Palmer,et al.  Adenosine receptors , 1995, Neuropharmacology.

[30]  E. Vizi,et al.  Adenosine receptor signaling in the brain immune system. , 2005, Trends in pharmacological sciences.

[31]  A. El-Ansary,et al.  Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia , 2011, BMC neurology.

[32]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[33]  F. X. Guix,et al.  The physiology and pathophysiology of nitric oxide in the brain , 2005, Progress in Neurobiology.

[34]  H. D. Rosas,et al.  The therapeutic role of creatine in Huntington's disease. , 2005, Pharmacology & therapeutics.

[35]  W. Nyhan,et al.  Developmental disorder associated with increased cellular nucleotidase activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Hollander,et al.  An open trial of divalproex sodium in autism spectrum disorders. , 2001, The Journal of clinical psychiatry.

[37]  U. Rout,et al.  Are autistic and catatonic regression related? A few working hypotheses involving gaba, Purkinje cell survival, neurogenesis, and ECT. , 2006, International review of neurobiology.

[38]  C. McDougle,et al.  Neurochemistry in the pathophysiology of autism. , 2005, The Journal of clinical psychiatry.

[39]  A. Bacha,et al.  Relationship between chronic lead toxicity and plasma neurotransmitters in autistic patients from Saudi Arabia. , 2011, Clinical biochemistry.

[40]  H Zimmermann,et al.  5'-Nucleotidase: molecular structure and functional aspects. , 1992, The Biochemical journal.

[41]  D. Geier,et al.  Autism spectrum disorder-associated biomarkers for case evaluation and management by clinical geneticists , 2008, Expert review of molecular diagnostics.

[42]  J. Baio,et al.  Prevalence of Autism Spectrum Disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 58, Number SS-10. , 2009 .

[43]  S. R. Crouch,et al.  Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia , 1977 .

[44]  H. Savaş,et al.  Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[45]  M. Litt,et al.  Adenosine deaminase activity decreased in autism. , 1982, Journal of the American Academy of Child Psychiatry.

[46]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[47]  T. Page.  Metabolic Approaches to the Treatment of Autism Spectrum Disorders , 2000, Journal of autism and developmental disorders.

[48]  D. Allan Butterfield,et al.  Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins , 2001, Mechanisms of Ageing and Development.

[49]  S. Eckstein.  Ethical principles for medical research involving human subjects. , 2001, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[50]  A. El-Ansary,et al.  Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. , 2010, Clinical biochemistry.

[51]  M. Beal,et al.  Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders , 2001, Annals of neurology.

[52]  A. El-Ansary,et al.  Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia , 2011, Journal of Neuroinflammation.

[53]  Maurice Place,et al.  The developmental, dimensional and diagnostic interview (3di): a novel computerized assessment for autism spectrum disorders. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[54]  M. Wyss,et al.  Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? , 2002, Neuroscience.

[55]  T. Dunwiddie,et al.  The Role and Regulation of Adenosine in the Central Nervous System , 2022 .

[56]  K. Shetty,et al.  HPLC method for amino acids profile in biological fluids and inborn metabolic disorders of aminoacidopathies , 2002, Indian Journal of Clinical Biochemistry.

[57]  B. Luhovyy,et al.  Brain amino acid requirements and toxicity: the example of leucine. , 2005, The Journal of nutrition.

[58]  M. Guazzi,et al.  Phosphodiesterase-5 Inhibition Abolishes Neuron Apoptosis Induced by Chronic Hypoxia Independently of Hypoxia-Inducible Factor-1α Signaling , 2008, Experimental biology and medicine.

[59]  P. D. De Deyn,et al.  Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis. , 1997, Metabolism: clinical and experimental.

[60]  A. Lehninger.  Principles of Biochemistry , 1984 .

[61]  H. Iizuka,et al.  TWO FORMS OF ADENOSINE DEAMINASE IN PIG EPIDERMIS (II) , 1982, The Journal of dermatology.